Main > ONCOLOGY (**) > Thyroid Cancer>MET>RET Fusion+ > TREAT.: > USA. B. Pralsetinib Capsules

---

USA. B. Pralsetinib Capsules's subsections
(*) USA Approval Date: 2020. 12.01.
Company
Company Partner
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2021. 02.09.
TradeMark
TradeMark Web-Site

USA. B. Pralsetinib Capsules's products
This section has no products